Trend

Last Previous Currency Date Chng
870.16 888.24 USD 26/05/07 -2.04

Terms

Isin LU0133359157
Contract Type Sicav
Currency USD
Class N
Risk Class 5
Assogestioni Category Azionari Salute
Declared Benchmark 100% Nasdaq Biotechnology Net TR Index
Start Date 02/08/22
Advisor Name Rudi Van den Eynde
Fund Asset Under Management 50,5183  at 26/03/31

Performance

Cumulatives
1 month +0.14
Ytd +4.33
1 year +53.84
3 years +44.29
5 years +63.03
Yearly
04/30/2025 +22.07
04/30/2024 +8.68
04/30/2023 +3.06
04/30/2022 +4.13
04/30/2021 +4.97
Rating
N.Av.
Score
N.Av.

Company

Candriam
Serenity Bloc B 19-21, route d�Arlon L-8009 - Strassen
Tel. +352-27975130

Costs

Entrance (ACP) Min: 0,0000 - Max: 0,0000
Management 2
Reimbursement 0%
Administrative 0,4%
Switch 0%
Tunnel 0

Subscription

One Solution
Initial N.Av. USD
Integrative 0,0000 USD
Accumulation Plan
Duration N.Av.
Minimum Payment Unit N.Av.
Initial Payment N.Av.

Costs

Entrance (ACP) Min: 0,0000 - Max: 0,0000
Management 2
Reimbursement 0%
Administrative 0,4%
Switch 0%
Tunnel 0

Performance

Cumulatives
1 day -2.10
1 week +0.54
1 month +0.14
3 months +1.38
6 months +11.12
From the beginning of the year +4.33
1 year +53.84
2 years +34.57
3 years +44.29
4 years +68.97
5 years +63.03
Yearly
04/30/2025 +22.07
04/30/2024 +8.68
04/30/2023 +3.06
04/30/2022 +4.13
04/30/2021 +4.97


Rating
N.Av.
Score
N.Av.

Efficiency Indicators

Sharpe 1 year 1.9504
Benchmark 1 year N.Av.
Sharpe 3 years 0.6403
Benchmark 3 years N.Av.
Sharpe 5 years 0.5058
Benchmark 5 years N.Av.
Sortino 1 year 5.8649
Benchmark 1 year N.Av.
Sortino 3 years 1.1142
Benchmark 3 years N.Av.
Sortino 5 years 0.8459
Benchmark 5 years N.Av.

Absolute

Standard Volatility
1 year +18.78
3 years +17.86
5 years +16.93
Negative Volatility
1 year +6.25
3 years +10.27
5 years +10.12

Benchmark

Standard Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Negative Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Updated Monthly - 26/04/30

Relative

Sharpe 0.6403
Sortino 1.1142
Bull Market +9.59
Bear Market -3.84
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Three years data
Risk Class 5

General

  1 year 17,918 3 years 15,839 5 years 14,143
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,918
11,740
  
+44.06
3 years 15,839
3,394
  
+47.01
5 years 14,143
2,316
  
+56.91
Performance
11,740 +44.06 3,394 +47.01 2,316 +56.91
Total Volatility
1 year 17,918
17,795
  
+18.78
3 years 15,839
14,683
  
+17.86
5 years 14,143
12,639
  
+16.93
Total Volatility
17,795 +18.78 14,683 +17.86 12,639 +16.93
Negative Volatility
1 year 17,918
16,380
  
+6.25
3 years 15,839
8,704
  
+10.27
5 years 14,143
10,647
  
+10.12
Negative Volatility
16,380 +6.25 8,704 +10.27 10,647 +10.12
Sharpe Index
1 year 17,918
15,293
  
+1.95
3 years 15,839
5,688
  
+0.64
5 years 14,143
4,141
  
+0.51
Sharpe Index
15,293 +1.95 5,688 +0.64 4,141 +0.51
Sortino Index
1 year 17,918
14,501
  
+5.86
3 years 15,839
2,291
  
+1.11
5 years 14,143
2,759
  
+0.85
Sortino Index
14,501 +5.86 2,291 +1.11 4,141 +0.85

By Category

  1 year 17,918 3 years 15,839 5 years 14,143
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,918
60
  
+44.06
3 years 15,839
39
  
+47.01
5 years 14,143
41
  
+56.91
Performance
60 +44.06 39 +47.01 41 +56.91
Total Volatility
1 year 17,918
45
  
+18.78
3 years 15,839
50
  
+17.86
5 years 14,143
46
  
+16.93
Total Volatility
45 +18.78 50 +17.86 46 +16.93
Negative Volatility
1 year 17,918
31
  
+6.25
3 years 15,839
43
  
+10.27
5 years 14,143
49
  
+10.12
Negative Volatility
31 +6.25 43 +10.27 49 +10.12
Sharpe Index
1 year 17,918
62
  
+1.95
3 years 15,839
50
  
+0.64
5 years 14,143
48
  
+0.51
Sharpe Index
62 +1.95 50 +0.64 48 +0.51
Sortino Index
1 year 17,918
61
  
+5.86
3 years 15,839
41
  
+1.11
5 years 14,143
43
  
+0.85
Sortino Index
61 +5.86 41 +1.11 43 +0.85

Foreign Funds - Candriam Eq. L Biotechnology N $: Performance, Terms, Fees, Risk, Rating


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.